Validation of a simple method for atrial fibrillation screening in patients with stroke

Neurological Sciences

Volumn 36, Issue 9, 2015, Pages 1675-1678

  Gandolfo, C ^a   Balestrino, M ^a   Bruno, C ^a   Finocchi, C ^a   Reale, N ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Accuracy; AFib device; Atrial fibrillation; Sensitivity; Specificity; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIOLOGIST; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GOLD STANDARD; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT; RELIABILITY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; BLOOD PRESSURE MONITOR; COMPLICATION; DEVICES; ELECTROCARDIOGRAPHY; HEART FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BLOOD PRESSURE MONITORS; ELECTROCARDIOGRAPHY; FEMALE; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 84957427316     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-015-2231-0     Document Type: Article

References (23)

1. Wolf P, Abbott R, Kannel W (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988
2. Go A, Hylek E, Phillips K, Chang Y, Henault L, Selby J, Singer D (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375
3. Miyasaka Y, Barnes M, Gersh B, Cha S, Bailey K, Abhayaratna W, Seward J, Tsang T (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980–2000, and implications on the projections for future prevalence. Circulation 114:119–125
4. Kimura K, Minematsu K, Yamaguchi T, Japan Multicenter Stroke Investigators’ Collaboration (J-MUSIC) (2005) Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 76:679–683
5. Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, Carolei A (2005) Contribution of atrial fibrillation to incidence and outcome of ischemic stroke results from a population-based study. Stroke 36:1115–1119
6. Gandolfo C, Balestrino M, Burrone A, Del Sette M, Finocchi C (2008) Stroke due to atrial fibrillation and the attitude to prescribing anticoagulant prevention in Italy. A prospective study of a consecutive stroke population admitted to a comprehensive stroke unit. J Neurol 255:796–802
7. Furie KL, Goldstein LB, Albers GW, Khatri P, Neyens R, Turakhia MP, Turan TN, Wood KA, American Heart Association Stroke Council, Council on Quality of Care and Outcomes Research, Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Peripheral Vascular Disease (2012) Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 43:3442–3453
8. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, ESC Committee for Practice Guidelines-CPG (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm Association. Europace 14:1385–1413
9. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151
10. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, ROCKET AF Investigators (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883–891
11. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981–992
12. Wiesel J, Wiesel D, Suri R, Messineo FC (2004) The use of a modified sphygmomanometer to detect atrial fibrillation in outpatients. PACE 27:639–643
13. Stergiou GS, Karpettas N, Protogerou A, Nasothimiou EG, Kyriakidis M (2009) Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation. J Hum Hyperten 23:654–658
14. Wiesel J, Fitzig L, Herschman Y, Messineo FC (2009) Detection of atrial fibrillation using a modified Microlife blood pressure monitor. Am J Hypertens 22:848–852
15. Wiesel J, Abraham S, Messineo FC (2013) Screening for asymptomatic atrial fibrillation while monitoring the blood pressure at home: trial of regular versus irregular pulse for prevention of stroke (TRIPPS 2.0). Am J Cardiol 111:1598–1601
16. Armitage P, Berry G (1998) Statistical methods in medical research, 3rd edn. Blackwell, London
17. Simel DL, Samsa GP, Matchar DB (2001) Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 44:763–770
18. Langhorne P, de Villiers L, Pandian JD (2012) Applicability of stroke-unit care to low-income and middle-income countries. Lancet Neurol 11:341–348
19. Lowres N, Neubeck L, Redfern J, Freedman SB (2013) Screening to identify unknown atrial fibrillation. A systematic review. Thromb Haemost 110:213–222
20. Lau JK, Lowres N, Neubeck L et al (2013) iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol 165:193–194
21. McManus DD, Lee J, Maitas O, Esa N, Pidikiti R, Carlucci A, Harrington J, Mick E, Chon KH (2013) A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation. Heart Rhythm 10:315–319
22. Leary MC, Veluz JS, Caplan LR (2014) Neurologic complications of arrhythmia treatment. In: Biller J, Ferro JM (eds) Neurologic aspects of systemic disease part I, Chap 10. Handbook of Clinical Neurology, vol 119. Elsevier, Amsterdam, pp 129–150
23. Suzuki S, Sagara K, Otsuka T, Kano H, Matsuno S, Takai H, Uejima T, Oikawa Y, Koike A, Nagashima K, Kirigaya H, Yajima J, Tanabe H, Sawada H, Aizawa T, Yamashita T (2013) Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation. Am J Cardiol 111:1602–1607